vs
Side-by-side financial comparison of AMN HEALTHCARE SERVICES INC (AMN) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $748.2M, roughly 1.5× AMN HEALTHCARE SERVICES INC). AMN HEALTHCARE SERVICES INC runs the higher net margin — -1.0% vs -127.8%, a 126.8% gap on every dollar of revenue. On growth, AMN HEALTHCARE SERVICES INC posted the faster year-over-year revenue change (1.8% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $67.6M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -4.5%).
AMN Healthcare Services Inc. is a leading US healthcare sector workforce solutions and staffing provider. It offers temporary and permanent placement for nurses, physicians, allied health and other clinical/non-clinical staff, plus workforce management tools and consulting for hospitals, clinics and other medical facilities.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
AMN vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $748.2M | $1.1B |
| Net Profit | $-7.7M | $-1.4B |
| Gross Margin | 26.1% | 32.6% |
| Operating Margin | 1.1% | -116.0% |
| Net Margin | -1.0% | -127.8% |
| Revenue YoY | 1.8% | -2.5% |
| Net Profit YoY | 95.9% | -3093.9% |
| EPS (diluted) | $-0.19 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $748.2M | $1.1B | ||
| Q3 25 | $634.5M | $1.0B | ||
| Q2 25 | $658.2M | $1.1B | ||
| Q1 25 | $689.5M | $1.0B | ||
| Q4 24 | $734.7M | $1.1B | ||
| Q3 24 | $687.5M | $1.1B | ||
| Q2 24 | $740.7M | $1.1B | ||
| Q1 24 | $820.9M | $1.1B |
| Q4 25 | $-7.7M | $-1.4B | ||
| Q3 25 | $29.3M | $7.5M | ||
| Q2 25 | $-116.2M | $-8.4M | ||
| Q1 25 | $-1.1M | $-6.4M | ||
| Q4 24 | $-187.5M | $-44.4M | ||
| Q3 24 | $7.0M | $-21.0M | ||
| Q2 24 | $16.2M | $-108.4M | ||
| Q1 24 | $17.3M | $2.0M |
| Q4 25 | 26.1% | 32.6% | ||
| Q3 25 | 29.1% | 36.1% | ||
| Q2 25 | 29.8% | 34.4% | ||
| Q1 25 | 28.7% | 37.6% | ||
| Q4 24 | 29.8% | 33.9% | ||
| Q3 24 | 31.0% | 37.2% | ||
| Q2 24 | 31.0% | 37.0% | ||
| Q1 24 | 31.4% | 33.1% |
| Q4 25 | 1.1% | -116.0% | ||
| Q3 25 | 7.5% | 7.0% | ||
| Q2 25 | -18.8% | 4.3% | ||
| Q1 25 | 1.8% | 4.5% | ||
| Q4 24 | -27.6% | 10.0% | ||
| Q3 24 | 3.2% | 7.4% | ||
| Q2 24 | 5.1% | -2.5% | ||
| Q1 24 | 4.9% | -5.1% |
| Q4 25 | -1.0% | -127.8% | ||
| Q3 25 | 4.6% | 0.7% | ||
| Q2 25 | -17.7% | -0.8% | ||
| Q1 25 | -0.2% | -0.6% | ||
| Q4 24 | -25.5% | -3.9% | ||
| Q3 24 | 1.0% | -1.9% | ||
| Q2 24 | 2.2% | -10.2% | ||
| Q1 24 | 2.1% | 0.2% |
| Q4 25 | $-0.19 | $-10.23 | ||
| Q3 25 | $0.76 | $0.05 | ||
| Q2 25 | $-3.02 | $-0.06 | ||
| Q1 25 | $-0.03 | $-0.05 | ||
| Q4 24 | $-4.90 | $-0.32 | ||
| Q3 24 | $0.18 | $-0.15 | ||
| Q2 24 | $0.42 | $-0.79 | ||
| Q1 24 | $0.45 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | — |
| Total DebtLower is stronger | $767.1M | — |
| Stockholders' EquityBook value | $642.1M | $2.9B |
| Total Assets | $2.1B | $8.5B |
| Debt / EquityLower = less leverage | 1.19× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.0M | — | ||
| Q3 25 | $52.6M | $432.1M | ||
| Q2 25 | $41.5M | $454.2M | ||
| Q1 25 | $55.8M | $409.9M | ||
| Q4 24 | $10.6M | $558.8M | ||
| Q3 24 | $30.6M | $1.5B | ||
| Q2 24 | $48.0M | $542.8M | ||
| Q1 24 | $50.6M | $658.5M |
| Q4 25 | $767.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $642.1M | $2.9B | ||
| Q3 25 | $644.4M | $4.4B | ||
| Q2 25 | $607.6M | $4.5B | ||
| Q1 25 | $715.1M | $4.4B | ||
| Q4 24 | $706.6M | $4.3B | ||
| Q3 24 | $890.7M | $4.6B | ||
| Q2 24 | $876.9M | $4.5B | ||
| Q1 24 | $854.2M | $4.7B |
| Q4 25 | $2.1B | $8.5B | ||
| Q3 25 | $2.1B | $10.1B | ||
| Q2 25 | $2.2B | $10.1B | ||
| Q1 25 | $2.4B | $9.8B | ||
| Q4 24 | $2.4B | $9.6B | ||
| Q3 24 | $2.7B | $11.2B | ||
| Q2 24 | $2.8B | $10.4B | ||
| Q1 24 | $2.9B | $10.6B |
| Q4 25 | 1.19× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.6M | $175.4M |
| Free Cash FlowOCF − Capex | $67.6M | $148.6M |
| FCF MarginFCF / Revenue | 9.0% | 13.4% |
| Capex IntensityCapex / Revenue | 1.1% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $233.8M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.6M | $175.4M | ||
| Q3 25 | $22.7M | $51.7M | ||
| Q2 25 | $78.5M | $75.9M | ||
| Q1 25 | $92.7M | $-64.5M | ||
| Q4 24 | $72.8M | $312.6M | ||
| Q3 24 | $66.7M | $42.2M | ||
| Q2 24 | $99.5M | $9.5M | ||
| Q1 24 | $81.4M | $-1.4M |
| Q4 25 | $67.6M | $148.6M | ||
| Q3 25 | $14.8M | $29.8M | ||
| Q2 25 | $68.7M | $56.7M | ||
| Q1 25 | $82.7M | $-90.0M | ||
| Q4 24 | $56.6M | $274.9M | ||
| Q3 24 | $47.4M | $15.1M | ||
| Q2 24 | $72.2M | $-18.9M | ||
| Q1 24 | $63.2M | $-26.5M |
| Q4 25 | 9.0% | 13.4% | ||
| Q3 25 | 2.3% | 2.9% | ||
| Q2 25 | 10.4% | 5.4% | ||
| Q1 25 | 12.0% | -8.6% | ||
| Q4 24 | 7.7% | 24.2% | ||
| Q3 24 | 6.9% | 1.4% | ||
| Q2 24 | 9.8% | -1.8% | ||
| Q1 24 | 7.7% | -2.4% |
| Q4 25 | 1.1% | 2.4% | ||
| Q3 25 | 1.2% | 2.1% | ||
| Q2 25 | 1.5% | 1.8% | ||
| Q1 25 | 1.4% | 2.4% | ||
| Q4 24 | 2.2% | 3.3% | ||
| Q3 24 | 2.8% | 2.5% | ||
| Q2 24 | 3.7% | 2.7% | ||
| Q1 24 | 2.2% | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | 0.77× | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 9.54× | — | ||
| Q2 24 | 6.13× | — | ||
| Q1 24 | 4.70× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMN
| Travel Nurse Staffing | $208.3M | 28% |
| Allied Staffing | $146.9M | 20% |
| Labor Disruption Services | $124.3M | 17% |
| Technology And Workforce Solutions | $88.0M | 12% |
| Language Services | $69.9M | 9% |
| Other | $29.6M | 4% |
| International Nurse Staffing | $29.6M | 4% |
| Interim Leadership Staffing | $24.1M | 3% |
| Vendor Management Systems | $16.3M | 2% |
| Local Staffing | $8.6M | 1% |
| International Nurse Permanent Placement | $2.6M | 0% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
